
Chin Augmentation Market Report 2026
Global Outlook – By Procedure (Surgical, Non-Surgical), By Material Type (Implants, Dermal Fillers, Fat Grafting, Other Materials), By Gender (Female, Male), By End-Use (Hospitals, Cosmetic Clinics, Ambulatory Surgical Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Chin Augmentation Market Overview
• Chin Augmentation market size has reached to $1.21 billion in 2025 • Expected to grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Increasing Cosmetic Procedures Fuels Growth In Chin Augmentation • Market Trend: FDA Approvals For Advance Medical Solutions Is Gaining Popularity In The Chin Augmentation Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Chin Augmentation Market?
Chin augmentation, also known as genioplasty or mentoplasty, is a cosmetic surgical procedure that enhances the contour, size, and projection of the chin. This procedure can involve the use of implants or the reshaping of existing bone to achieve a more balanced facial profile. It is commonly sought to improve facial symmetry and aesthetics. The main procedure types for chin augmentation are surgical and non-surgical. Surgical refers to procedures or techniques involving operative intervention used to treat diseases, injuries, or conditions. The materials used are implants, dermal fillers, fat grafting, and others, and they are used for both genders, including female and male. It is used by various end-users, such as hospitals, cosmetic clinics, ambulatory surgical centers, and others.
What Is The Chin Augmentation Market Size and Share 2026?
The chin augmentation market size has grown strongly in recent years. It will grow from $1.21 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to growing acceptance of cosmetic surgery, increasing disposable income levels, advancements in implant materials, expansion of cosmetic clinics, rising influence of aesthetic awareness.What Is The Chin Augmentation Market Growth Forecast?
The chin augmentation market size is expected to see strong growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for non-surgical cosmetic treatments, growing adoption of AI-based facial analysis, expansion of medical tourism, rising preference for personalized aesthetic outcomes, continued innovation in biocompatible materials. Major trends in the forecast period include increasing demand for minimally invasive chin augmentation procedures, rising adoption of customized facial implants, growing use of dermal fillers for non-surgical enhancement, expansion of digital facial imaging and planning tools, enhanced focus on aesthetic personalization.Global Chin Augmentation Market Segmentation
1) By Procedure: Surgical, Non-Surgical 2) By Material Type: Implants, Dermal Fillers, Fat Grafting, Other Materials 3) By Gender: Female, Male 4) By End-Use: Hospitals, Cosmetic Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Surgical: Chin Implant Surgery, Genioplasty (Bone Surgery) 2) By Non-Surgical: Dermal Filler Injections, Botox Injections, Thread LiftsWhat Is The Driver Of The Chin Augmentation Market?
The growing number of cosmetic procedures is expected to propel the growth of the chin augmentation market going forward. Cosmetic procedures refer to medical treatments aimed at enhancing appearance and used to improve aesthetic features or correct physical imperfections. The number of cosmetic procedures is rising due to increasing societal emphasis on appearance and advancements in medical technology, making these procedures more accessible and safer. Chin augmentation enhances facial balance and profile aesthetics, making it popular in cosmetic procedures for improving overall facial harmony. For instance, in June 2024, according to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), a US based professional non-governmental organization, in 2023, there were total surgical and non-surgical aesthetic procedures procedures increased by 3.4% in 2023, up to 34.9 million. Showing a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons and 19.1 non-surgical procedures. Therefore, the growing number of cosmetic procedure is driving the growth of the chin augmentation industry.Key Players In The Global Chin Augmentation Market
Major companies operating in the chin augmentation market are AbbVie Inc., Stryker Corporation, Galderma Filler, Merz Pharma Gmbh and Co. Kgaa, InMode Ltd., KLS Martin Group, OsteoMed, Sientra Inc, GC Aesthetics Limited, Hans Biomed, POLYTECH Health and Aesthetics, Implantech Associates Inc, Sebbin Sas, Teoxane, Solta Medical Inc, Silimed, Lucid Implants, Surgiform Technologies, Facial Plastic Surgery Inc, Eurosurgical Ltd, Cadogan Clinic LtdGlobal Chin Augmentation Market Trends and Insights
Major companies operating in the chin augmentation market are focusing on developing technologically advanced medical solutions, such as hyaluronic acid (HA) dermal filler to meet the growing demand for non-surgical aesthetic enhancements and to provide safer and more effective options for enhancing facial features. Hyaluronic acid (HA) dermal filler is a gel-like substance injected into the skin to add volume, smooth wrinkles, and improve facial contours. For instance, in March 2024, AbbVie, a US based biotech company, announced that the U.S. Food and Drug Administration (FDA) had approved its JUVÉDERM VOLUMA, injectable gel is for deep injection for cheek augmentation to correct age-related volume loss in the mid-face, and for augmentation of the chin region to improve the chin profile in adults over 21.What Are Latest Mergers And Acquisitions In The Chin Augmentation Market?
In April 2024, Beverly JCG Ltd., a Singapore-based wellness and beauty company, acquired BK Aesthetic Clinic for an undisclosed amount. With this acquisition, Beverly JCG Ltd. aims to expand its footprint in the growing aesthetics and healthcare sectors while also leveraging the expertise and reputation of a renowned South Korean cosmetic surgeon to enhance its service offerings and financial performance. BK Aesthetic Clinic is a Singapore-based company that offers chin augmentation services.Regional Outlook
North America was the largest region in the chin augmentation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Chin Augmentation Market?
The chin augmentation market consists of revenues earned by entities providing services such as chin surgery, chin augmentation with neck liposuction, chin reduction surgery, and revision chin surgery. The market value includes the value of related goods sold by the service provider or included within the service offering. The chin augmentation market also includes sales of surgical instruments and equipment, dermal fillers and injectables, facial implants and augmentation kits, and post-operative care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Chin Augmentation Market Report 2026?
The chin augmentation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chin augmentation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Chin Augmentation Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.29 billion |
| Revenue Forecast In 2035 | $1.65 billion |
| Growth Rate | CAGR of 6.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Procedure, Material Type, Gender, End-Use |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | AbbVie Inc., Stryker Corporation, Galderma Filler, Merz Pharma Gmbh and Co. Kgaa, InMode Ltd., KLS Martin Group, OsteoMed, Sientra Inc, GC Aesthetics Limited, Hans Biomed, POLYTECH Health and Aesthetics, Implantech Associates Inc, Sebbin Sas, Teoxane, Solta Medical Inc, Silimed, Lucid Implants, Surgiform Technologies, Facial Plastic Surgery Inc, Eurosurgical Ltd, Cadogan Clinic Ltd |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
